Last update: Aug. 12, 2014

Pilocarpine Ophtalmic Use

Very Low Risk for breastfeeding


Safe. Compatible.
Not risky for breastfeeding or infant.

Topical treatment of glaucoma. Like most ophthalmologic compounds for topical use, a low dose and poor absorption make it compatible with breastfeeding. Eye pomades are preferred, or, by pressing conjunctiva sack for a couple of minutes to lessen systemic absorption.

Alternatives

We do not have alternatives for Pilocarpine Ophtalmic Use since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.
DONATE NOW

Group

Pilocarpine Ophtalmic Use belongs to this group or family:

Tradenames

Main tradenames from several countries containing Pilocarpine Ophtalmic Use in its composition:

Pharmacokinetics

Variable Value Unit
Bioavailability Alta - Hig %
Molecular weight 208 daltons
Protein Binding 0 %
Tmax 1,3 hours
T1/2 1,6 hours

References

  1. WHO / UNICEF. BREASTFEEDING AND MATERNAL MEDICATION Recommendations for Drugs in the Eleventh WHO Model List of Essential Drugs. Department of Child and Adolescent Health and Development (WHO/UNICEF) 2002 Full text (link to original source) Full text (in our servers)

Total visits

1,780

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana from Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM